Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study.

BACKGROUND: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. METHODS: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. RESULTS: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. CONCLUSIONS: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.

Psychological Impact of the Pandemic on Ambulatory Cardiometabolic Patients Without Evidence of SARS-CoV-2 Infection. The CorCOVID Latam Psy Study.

BACKGROUND: The COVID-19 pandemic's mental health consequences remain unknown. AIM: To assess the mental health status of ambulatory cardiometabolic patients during COVID-19 pandemic lockdown in Spanish speaking Latin American countries. METHODS: Cardiometabolic patients without COVID-19 evidence in 13 Latin American countries answered a survey between June 15th and July 15th, 2020. The Diagnosis Manual of Mental Disorders fifth edition was used to identify the presence of major depressive symptoms. RESULTS: The sample included 4216 patients, 1590 (37.71%; IC95% 36.24-39.19) were considered suffering major depression. Female gender, consuming ≥5 medications day, physical activity <100 minutes weekly, low fruits and vegetables intake, poor treatment adherence, reduced food consumption were independently associated to the presence of major depressive symptoms. CONCLUSIONS: The CorCOVID Latam Psy study showed that one-third of the Latin American Spanish speaking population is suffering from major depressive symptoms during the COVID-19 outbreak.

Fibrilación ventricular secundaria a la aplicación de radiofrecuencia en la ablación de una taquicardia ventricular / Ventricular Fibrillation Secondary to Radiofrequency Application for Ventricular Tachycardia Ablation

La ablación con catéter mediante radiofrecuencia se ha establecido como un tratamiento de elección en diversos tipos de taquicardias por su elevada eficacia y bajo porcentaje de complicaciones. La aparición de complicaciones proarrítmicas por efecto directo de la radiofrecuencia es muy infrecuente. Describimos el caso de un paciente con infarto de miocardio antiguo y taquicardia ventricular monomórfica sostenida bien tolerada, sometido a ablación con catéter del sustrato de la misma, que durante dos de las aplicaciones de radiofrecuencia desarrolló fibrilación ventricular que requirió desfibrilación externa (AU)

Efecto proarrítmico tras la ablación con radiofrecuencia de una arritmia ventricular monomórfica repetitiva / Proarrhythmic effect following radiofrequency catheter ablation of repetitive monomorphic ventricular arrhythmia

La ablación con radiofrecuencia es un tratamiento de primera línea para una gran cantidad de taquiarritmias supraventriculares y algunas ventriculares, por su alta tasa de éxitos y baja probabilidad de complicaciones. Aunque la mayoría de éstas se relacionan con la técnica de cateterismo, algunas se deben al propio efecto de la radiofrecuencia. Presentamos el caso de un paciente con arritmia ventricular repetitiva no sostenida que tras la ablación eficaz con radiofrecuencia desarrolló una taquicardia ventricular monomórfica sostenida e incesante que requirió un nuevo procedimiento de ablación (AU)